$4.46
3.04% today
Nasdaq, Nov 13, 07:43 pm CET
ISIN
US81728J1097
Symbol
SRTS

Sensus Healthcare, Inc. Stock price

$4.60
+1.39 43.30% 1M
+0.05 1.10% 6M
-2.32 33.53% YTD
-2.55 35.66% 1Y
-3.00 39.47% 3Y
+1.94 72.93% 5Y
-1.25 21.37% 10Y
-1.25 21.37% 20Y
Nasdaq, Closing price Wed, Nov 12 2025
+0.39 9.26%

Key metrics

Basic
Market capitalization
$75.6m
Enterprise Value
$53.5m
Net debt
positive
Cash
$22.2m
Shares outstanding
16.4m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.0 | 2.4
EV/Sales
1.4 | 1.7
EV/FCF
15.3
P/B
1.5
Financial Health
Equity Ratio
89.8%
Return on Equity
11.9%
ROCE
-2.6%
ROIC
-7.7%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$37.6m | $31.4m
EBITDA
$-1.1m | $-3.9m
EBIT
$-1.4m | $-4.0m
Net Income
$-850.0k | $-5.5m
Free Cash Flow
$3.5m
Growth (TTM | estimate)
Revenue
3.3% | -24.8%
EBITDA
-112.9% | -147.3%
EBIT
-116.0% | -149.9%
Net Income
-112.8% | -183.2%
Free Cash Flow
420.2%
Margin (TTM | estimate)
Gross
52.2%
EBITDA
-3.0% | -12.5%
EBIT
-3.6%
Net
-2.3% | -17.6%
Free Cash Flow
9.3%
More
EPS
$-0.1
FCF per Share
$0.2
Short interest
3.9%
Employees
54
Rev per Employee
$770.0k
Show more

Is Sensus Healthcare, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,031 stocks worldwide.

Sensus Healthcare, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Sensus Healthcare, Inc. forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a Sensus Healthcare, Inc. forecast:

Buy
90%
Hold
10%

Financial data from Sensus Healthcare, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
38 38
3% 3%
100%
- Direct Costs 18 18
24% 24%
48%
20 20
11% 11%
52%
- Selling and Administrative Expenses 14 14
48% 48%
39%
- Research and Development Expense 6.50 6.50
83% 83%
17%
-1.14 -1.14
113% 113%
-3%
- Depreciation and Amortization 0.23 0.23
26% 26%
1%
EBIT (Operating Income) EBIT -1.37 -1.37
116% 116%
-4%
Net Profit -0.85 -0.85
113% 113%
-2%

In millions USD.

Don't miss a Thing! We will send you all news about Sensus Healthcare, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sensus Healthcare, Inc. Stock News

Neutral
Business Wire
one day ago
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, today announced the appointment of Eric Sachetta to the Company's Board of Directors. Mr. Sachetta is filling the vacancy that resulted from the pa...
Neutral
Seeking Alpha
7 days ago
Sensus Healthcare, Inc. ( SRTS ) Q3 2025 Earnings Call November 6, 2025 4:30 PM EST Company Participants Joseph Sardano - Co-Founder, Chairman & CEO Michael Sardano - President, General Counsel, Corporate Secretary & Director Javier Rampolla - Chief Financial Officer Conference Call Participants Tirth Patel - Lippert/Heilshorn & Associates, Inc. Anthony Vendetti - Maxim Group LLC, Research Divi...
Neutral
Business Wire
7 days ago
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces financial results for the three and nine months ended September 30, 2025. Highlights of the third quarter of 2025 and subsequent weeks inc...
More Sensus Healthcare, Inc. News

Company Profile

Sensus Healthcare, Inc. operates as a medical device company, which provides treatments for both oncological and non-oncological skin conditions. The firm's portfolio of treatment devices includes the SRT-100, SRT-100+ and SRT-100 Vision. Its main product, superficial radiation therapy (SRT), a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating basal cell and squamous cell skin cancers and other skin conditions such as keloids. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.

Head office United States
CEO Joseph Sardano
Employees 54
Founded 2010
Website sensushealthcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today